A model to estimate the potential economic benefits of measles eradication for the United States
- 2 December 1998
- Vol. 16 (20) , 1917-1922
- https://doi.org/10.1016/s0264-410x(98)00125-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A benefit-cost analysis of two-dose measles immunization in CanadaVaccine, 1998
- Trends in importation of measles to the United States, 1986-1994Published by American Medical Association (AMA) ,1997
- Measles elimination in the Americas. Evolving strategiesPublished by American Medical Association (AMA) ,1996
- The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination ProgramNew England Journal of Medicine, 1994
- Increase of Vaccination Coverage by Mass Media and Individual Approach: Intensified Measles, Mumps, and Rubella Prevention Program in FinlandAmerican Journal of Epidemiology, 1991
- RAPID EFFECT ON ENDEMIC MEASLES, MUMPS, AND RUBELLA OF NATIONWIDE VACCINATION PROGRAMME IN FINLANDThe Lancet, 1986
- Benefits, risks and costs of immunization for measles, mumps and rubella.American Journal of Public Health, 1985
- THE CASE FOR GLOBAL MEASLES ERADICATIONPublished by Elsevier ,1982
- The opportunity and obligation to eliminate measles from the United StatesPublished by American Medical Association (AMA) ,1979
- Epidemiologic Basis for Eradication of Measles in 1967: A Statement by the Public Health ServicePublic Health Reports (1896-1970), 1967